Makers

Weight-Loss Drug Makers Navigate U.S. Litigation Landscape: Lessons from the Past and Strategies for Future Defense

by

Washington, D.C. – Amid booming sales, manufacturers of GLP-1 weight-loss drugs face a new challenge: the potential for mass tort litigation similar to what has historically rocked other sectors of the American pharmaceutical industry. Industry experts suggest that drawing lessons from past litigations could be key to these manufacturers not just surviving but thriving in an increasingly litigious environment. GLP-1, or glucagon-like peptide-1 receptor agonists, have gained attention not only for their effectiveness in obesity management but also for potential side effects which could become the focal point of legal battles. Given the aggressive nature … Read more

U.S. Judge Rejects Mexico’s Suit Against Gun Makers for a Second Time

by

Boston — In a significant legal decision, a U.S. federal judge has once again dismissed a lawsuit filed by the Mexican government against major U.S. gun manufacturers. The case, which had been closely watched by legal experts and international policymakers, accused these manufacturers of facilitating illegal arms trafficking and exacerbating violence within Mexico. The judge ruled that the claims could not proceed due to the broad protections afforded to gun makers under U.S. law, specifically referencing the Protection of Lawful Commerce in Arms Act. This 2005 legislation shields firearms manufacturers and dealers from being held … Read more

Weight-Loss Drug Makers Glean Strategic Insights from U.S. Litigation History

by

New York — As the United States grapples with rising obesity rates, manufacturers of the weight-loss drug class known as glucagon-like peptide-1 receptor agonists, or GLP-1, are drawing increased legal scrutiny. With this pharmaceutical success comes a lurking fear of mass tort litigation, a recurring theme in America’s complicated relationship with promising yet potentially risky medications. GLP-1 weight-loss drugs, lauded for their effectiveness in combating obesity, now face the challenge of navigating the perilous waters of American litigation. This scenario isn’t new. The history of pharmaceuticals in the U.S. is replete with legal battles over … Read more

Powerful Change Makers Chosen: APAC Tambuli Awards Unveil 2024 Jury for Builders of Society Categories

by

Hong Kong, China – The APAC Tambuli Awards has announced the jury for the 2024 Builders of Society Categories. This prestigious event recognizes advertising campaigns that promote positive social change. The awards, established in 2005, celebrate brands that contribute to the betterment of society through their impactful initiatives. The jury for the 2024 awards consists of esteemed professionals from various industries, ensuring a diverse and well-rounded perspective. This year’s jury includes experts from advertising, marketing, and communications backgrounds who will assess the submissions and select the winners. The APAC Tambuli Awards aim to honor campaigns … Read more